Vivian Cong (weina)

Vivian (Weina) Cong has a diverse work experience in the field of research and development. Vivian(weina) currently holds the position of VP of Research and Development at Melior Discovery since April 2022. Prior to this, they served as a Senior Scientific Director at the same company from April 2021 to April 2022. Vivian(weina) also worked as the Director of Cardiovascular & Metabolic Disease at Melior Discovery from an unspecified date in 2016 to April 2021.

Before joining Melior Discovery, Vivian worked as a Researcher at the National Institutes of Health from January 2010 to an unspecified date in 2015. Their research focused on investigating the therapeutic effects of Amitriptyline on neurodegeneration using a mouse model of Huntington's disease.

Vivian(weina) also gained experience as a Postdoctoral Research Fellow at The Hospital for Sick Children from September 2008 to December 2009. Their research focused on hepatic insulin resistance, leptin resistance, and the correlation between leptin signaling and lipid metabolism in both the liver and hypothalamus.

Vivian (Weina) Cong completed their education history as follows:

From 1998 to 2003, they attended Shenyang Pharmaceutical University and earned a Bachelor of Science (B.S.) degree in Pharmacy.

Following that, from 2003 to 2008, they pursued a Ph.D. at Peking Union Medical College, specializing in Pharmacology in obesity and diabetes.

In addition to their formal education, Vivian has obtained certifications in various subjects, including Google Data Analytics Specialization from Coursera.

Vivian has also completed multiple certifications from The Wharton School, including Accounting Analytics, Customer Analytics, Introduction to Corporate Finance, Introduction to Financial Accounting, Introduction to Marketing, Introduction to Operations Management, and Managing Social and Human Capital. The specific dates of obtaining these certifications are not provided.